A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Hirako, Naomi ^a   Nakano, Hiroko ^b   Takahashi, Shinichiro ^a,b  

^a KITASATO UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLYCOPROTEIN P 15095; MESSENGER RNA; METALLOTHIONEIN; METALLOTHIONEIN IG; MYC PROTEIN; MYELOPEROXIDASE; NEUTROPHIL COLLAGENASE; NITROBLUE TETRAZOLIUM; ONCOSTATIN M; RETINOIC ACID; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; MT1G PROTEIN, HUMAN; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ARTICLE; AZUROCIDIN 1 GENE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GATA2 GENE; GENE; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MATRIX METALLOPEPTIDASE 8 GENE; MICROARRAY ANALYSIS; NB4MTOE CELL LINE; NEUTROPHIL CYTOSOLIC FACTOR 2 GENE; NITROBLUE TETRAZOLIUM TEST; ONCOSTATIN M GENE; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PYRROLINE 5 CARBOXYLATE REDUCTASE 1 GENE; REAL TIME POLYMERASE CHAIN REACTION; S100 CALCIUM BINDING PROTEIN A12 GENE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPHENOTYPING; METABOLISM; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, PROMYELOCYTIC, ACUTE; METALLOTHIONEIN; PROTO-ONCOGENE PROTEINS; REPRODUCIBILITY OF RESULTS; TRANS-ACTIVATORS; TRETINOIN;

EID: 84904998184     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103282     Document Type: Article

References (43)

1. Takahashi S (2012) Molecular functions of metallothionein and its role in hematological malignancies. J Hematol Oncol 5: 41.
2. Cherian MG, Jayasurya A, Bay BH (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533: 201-209. (Pubitemid 37487869)
3. Moffatt P, Denizeau F (1997) Metallothionein in physiological and physiopathological processes. Drug Metab Rev 29: 261-307. (Pubitemid 27293613)
4. Searle PF, Davison BL, Stuart GW, Wilkie TM, Norstedt G, et al. (1984) Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol Cell Biol 4: 1221-1230. (Pubitemid 16242517)
5. Uchida Y, Takio K, Titani K, Ihara Y, Tomonaga M (1991) The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Neuron 7: 337-347.
6. Quaife CJ, Findley SD, Erickson JC, Froelick GJ, Kelly EJ, et al. (1994) Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. Biochemistry 33: 7250-7259. (Pubitemid 24208763)
7. Karin M, Richards RI (1982) Human metallothionein genes - primary structure of the metallothionein-II gene and a related processed gene. Nature 299: 797-802. (Pubitemid 12003298)
8. Richards RI, Heguy A, Karin M (1984) Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. Cell 37: 263-272. (Pubitemid 14079858)
9. Chen HM, Zhang P, Voso MT, Hohaus S, Gonzalez DA, et al. (1995) Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85: 2918-2928.
10. Scott EW, Simon MC, Anastasi J, Singh H (1994) Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265: 1573-1577.
11. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, et al. (2004) Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 36: 624-630. (Pubitemid 38715991)
12. Imoto A, Okada M, Okazaki T, Kitasato H, Harigae H, et al. (2010) Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. J Biol Chem 285: 10300-10309.
13. Inomata M, Takahashi S, Harigae H, Kameoka J, Kaku M, et al. (2006) Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. Leuk Res 30: 659-664.
14. Takahashi S, Harigae H, Kameoka J, Sasaki T, Kaku M (2005) AML1B transcriptional repressor function is impaired by the Flt3 internal tandem duplication. Br J Haematol 130: 428-436. (Pubitemid 43899593)
15. Aoyama S, Nakano H, Danbara M, Higashihara M, Harigae H, et al. (2012) The differentiating and apoptotic effects of 2-aza-5′-deoxycytidine are dependent on the PU.1 expression level in PU.1-transgenic K562 cells. Biochem Biophys Res Commun 420: 775-781.
16. Hirosawa M, Nakahara M, Otosaka R, Imoto A, Okazaki T, et al. (2009) The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells. Leuk Res 33: 693-699.
17. Tabe Y, Konopleva M, Contractor R, Munsell M, Schober WD, et al. (2006) Up-regulation of MDR1 and induction of doxorubicin resistance by histone deacetylase inhibitor depsipeptide (FK228) and ATRA in acute promyelocytic leukemia cells. Blood 107: 1546-1554. (Pubitemid 43242393)
18. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1979) Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149: 969-974. (Pubitemid 9154758)
19. Orkin SH (1992) GATA-binding transcription factors in hematopoietic cells. Blood 80: 575-581.
20. Garwicz D, Lennartsson A, Jacobsen SE, Gullberg U, Lindmark A (2005) Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 90: 38-44. (Pubitemid 40193752)
21. Phang JM, Pandhare J, Liu Y (2008) The metabolism of proline as microenvironmental stress substrate. J Nutr 138: 2008S-2015S.
22. Kaiser V, Diamond G (2000) Expression of mammalian defensin genes. J Leukoc Biol 68: 779-784.
23. Jinquan T, Quan S, Jacobi HH, Jing C, Millner A, et al. (2000) CXC chemokine receptor 3 expression on CD34(+) hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon gamma-inducible protein 10 and monokine induced by interferon gamma. Blood 96: 1230-1238. (Pubitemid 30658448)
24. Lopez-Otin C, Palavalli LH, Samuels Y (2009) Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle 8: 3657-3662.
25. Pietzsch J, Hoppmann S (2009) Human S100A12: a novel key player in inflammation? Amino Acids 36: 381-389.
26. Nauseef WM (2004) Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol 122: 277-291.
27. Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, et al. (2000) Role of Oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 11: 177-183. (Pubitemid 30337457)
28. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
29. Britschgi C, Jenal M, Rizzi M, Mueller BU, Torbett BE, et al. (2008) HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. Br J Haematol 141: 179-187. (Pubitemid 351406205)
30. Meplan C, Richard MJ, Hainaut P (2000) Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 19: 5227-5236.
31. Tsai FY, Orkin SH (1997) Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89: 3636-3643.
32. Kondo Y, Rusnak JM, Hoyt DG, Settineri CE, Pitt BR, et al. (1997) Enhanced apoptosis in metallothionein null cells. Mol Pharmacol 52: 195-201. (Pubitemid 27349610)
33. Fittschen C, Henson PM (1991) Selective secretion of azurophil granule contents induced by monovalent cation ionophores in human neutrophils: evidence for direct ionophore effects on the granule membrane. J Leukoc Biol 50: 517-528.
34. Abdel-Mageed AB, Zhao F, Rider BJ, Agrawal KC (2003) Erythropoietin- induced metallothionein gene expression: role in proliferation of K562 cells. Exp Biol Med (Maywood) 228: 1033-1039. (Pubitemid 37222172)
35. Maghdooni Bagheri P, Govaerts I, De Ley M (2011) Role of metallothionein in differentiation of leukemia cells. Mol Biol Rep 38: 3017-3022.
36. Michalska AE, Choo KH (1993) Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A 90: 8088-8092. (Pubitemid 23260860)
37. Masters BA, Kelly EJ, Quaife CJ, Brinster RL, Palmiter RD (1994) Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 91: 584-588. (Pubitemid 24041446)
38. Liu J, Liu Y, Habeebu SS, Klaassen CD (1999) Metallothionein-null mice are highly susceptible to the hematotoxic and immunotoxic effects of chronic CdCl2 exposure. Toxicol Appl Pharmacol 159: 98-108. (Pubitemid 29426581)
39. Sugiura T, Kuroda E, Yamashita U (2004) Dysfunction of macrophages in metallothionein-knock out mice. J Uoeh 26: 193-205. (Pubitemid 38855688)
40. Sauerbrey A, Zintl F, Hermann J, Volm M (1998) Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). Anticancer Res 18: 1231-1236. (Pubitemid 28234022)
41. Ozeki K, Kiyoi H, Hirose Y, Iwai M, Ninomiya M, et al. (2004) Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. Blood 103: 1901-1908. (Pubitemid 38268989)
42. Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, et al. (2005) Detailed analysis of FLT3 expression levels in acute myeloid leukemia. Haematologica 90: 1617-1625. (Pubitemid 41814985)
43. Torlakovic EE, Bilalovic N, Golouh R, Zidar A, Angel S (2006) Prognostic significance of PU.1 in follicular lymphoma. J Pathol 209: 352-359. (Pubitemid 43997744)